Abu Dhabi-based technology company Group 42 (G42) has formed a joint venture with Israel’s state-owned Rafael Advanced Defense Systems to commercialize artificial intelligence and big data technologies, the companies said on Monday.
The joint venture, called Presight.AI, will have a research and development site in Israel and will develop products for sectors including banking, healthcare and public safety, to be sold in Israel, the United Arab Emirates and internationally.
For the latest headlines, follow our Google News channel online or via the app.
Israel and the UAE agreed to normalize relations in August, triggering a number of announcements from businesses stating their intention to cooperate across the two countries.
UAE Ambassador to Israel Mohamad al-Khaja said the joint venture strengthened the relationship between Israel and the UAE and opportunities for bilateral economic growth.
G42 is an Abu Dhabi-based artificial intelligence and cloud computing company set up in 2018 which works with government and private clients. In September it became the first UAE company to open an international office in Israel.
UAE national security advisor Sheikh Tahnoon bin Zayed Al Nahyan is its chairman and a shareholder. Abu Dhabi’s sovereign fund Mubadala in November invested in G42 and last week US private-equity firm Silver Lake invested to help the company expand.
G42 rose to prominence last year as it led Phase III clinical trials of a vaccine developed by Sinopharm’s China National Biotec Group (CNBG) in the UAE and regional countries, as well as offering medical diagnostic services.
The joint venture agreement is subject to regulatory approvals by Israeli and UAE authorities.
No one who received Sinopharm vaccine doses has died of COVID-19 in Abu Dhabi: StudyNo one has died from COVID-19-related causes in Abu Dhabi, United Arab Emirates after receiving all “required” doses of the Sinopharm vaccine, ... Coronavirus
New Abu Dhabi plant to make COVID-19 vaccine from China’s SinopharmA new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint ... Coronavirus
UAE prioritized early availability, local production in picking Sinopharm vaccineThe United Arab Emirates hinged its inoculation program on the vaccine developed by China’s Sinopharm Group, given early availability and the ... Coronavirus
UAE’s Al Naboodah to tie up with Israeli VC OurCrowd on technologyIsraeli venture investment firm OurCrowd signed a memorandum of understanding with UAE’s Phoenix, a business development company, to increase business ... Technology